Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
0.9900
-0.1170 (-10.57%)
May 26, 2026, 2:11 PM EST

Nuo Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.260.550.280.932.051.41
Cash & Short-Term Investments
0.260.550.280.932.051.41
Cash Growth
374.04%93.49%-69.45%-54.73%45.01%776.26%
Accounts Receivable
0.870.560.250.250.09-
Receivables
0.870.560.250.250.09-
Inventory
0.250.210.150.210.24-
Prepaid Expenses
0.130.060.160.170.20.05
Restricted Cash
----0.06-
Total Current Assets
1.521.380.841.562.631.47
Property, Plant & Equipment
0.430.470.350.310.41-
Total Assets
1.951.851.191.883.051.47
Accounts Payable
0.390.440.220.390.40.53
Accrued Expenses
0.590.490.290.190.120.15
Current Portion of Leases
0.080.080.070.090.08-
Current Unearned Revenue
0.310.3----
Total Current Liabilities
1.371.310.580.670.60.67
Long-Term Leases
-0.020.10.160.26-
Long-Term Unearned Revenue
0.940.98----
Other Long-Term Liabilities
1.030.5---0-
Total Liabilities
3.332.80.680.840.860.67
Common Stock
000000
Additional Paid-In Capital
3433.8132.7730.9728.9524.38
Retained Earnings
-35.39-34.77-32.26-29.94-26.76-23.59
Total Common Equity
-1.38-0.960.511.042.190.79
Shareholders' Equity
-1.38-0.960.511.042.190.79
Total Liabilities & Equity
1.951.851.191.883.051.47
Total Debt
0.080.10.160.260.34-
Net Cash (Debt)
0.180.450.120.671.721.41
Net Cash Growth
-277.88%-82.25%-60.78%21.32%776.26%
Net Cash Per Share
0.000.010.000.020.040.05
Filing Date Shares Outstanding
48.4148.2946.8244.2441.837.12
Total Common Shares Outstanding
48.2948.1846.8244.2441.837.12
Working Capital
0.150.070.260.892.030.79
Book Value Per Share
-0.03-0.020.010.020.050.02
Tangible Book Value
-1.38-0.960.511.042.190.79
Tangible Book Value Per Share
-0.03-0.020.010.020.050.02
Machinery
-0.880.610.450.450.39
Source: S&P Global Market Intelligence. Standard template. Financial Sources.